AKT2 knockdown by RNA interference suppresses cell proliferation and induces apoptosis even increases chemosensitivity in lung adenocarcinoma [40], malignant gliomas [41,42], pancreatic cancer [43] and ovarian cancer [44]. Here, AKT2 is linked to ovarian cancer.